Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in HCV-Positive Egyptian Patients Treated with Sofosbuvir.
Ali NadaMohamed AbbasyAliaa SabryAzza Mohamed Abdu AllahSomaia Shehab-EldeenNada ElnaidanyHanan ElimamKawthar Ibraheem Mohamed IbraheemAbdallah EssaPublished in: Canadian journal of gastroenterology & hepatology (2020)
Sofosbuvir appears to have no nephrotoxic effects and is safe to treat patients with chronic HCV infection.